Marks Group Wealth Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-27,512
Closed -$6.03M 276
2021
Q1
$6.03M Sell
27,512
-2,419
-8% -$485K 0.89% 24
2020
Q4
$5.23M Sell
29,931
-839
-3% -$145K 0.82% 44
2020
Q3
$4.98M Buy
30,770
+2,176
+8% +$345K 0.9% 24
2020
Q2
$4.04M Sell
28,594
-5,219
-15% -$722K 0.82% 54
2020
Q1
$3.68M Buy
33,813
+2,899
+9% +$418K 0.95% 34
2019
Q4
$4.49M Buy
+30,914
New +$4.46M 0.88% 44

Other funds holding LH

Marks Group Wealth Management's LH Position: Q2 2021 in Review

Marks Group Wealth Management sold out of Labcorp (LH) in Q2 2021, closing a stake of 27,512 shares — an estimated $6.03M sold.

Marks Group Wealth Management first reported a position in LH in Q4 2019 and held it in 6 quarters. The position peaked at $6.03M in Q1 2021. 948 funds tracked by Wall St. Rank hold LH as of Q2 2021.

  • Marks Group Wealth Management reported no remaining Labcorp position as of Q2 2021 after selling out during the quarter.
  • Marks Group Wealth Management sold 27,512 Labcorp shares in Q2 2021, an estimated $6.03M.
  • Marks Group Wealth Management first reported a position in Labcorp in Q4 2019 and held it in 6 quarters.
  • Marks Group Wealth Management's Labcorp position peaked at $6.03M in Q1 2021.
  • 948 funds tracked by Wall St. Rank held Labcorp as of Q2 2021.

Based on Marks Group Wealth Management's 13F filing for Q2 2021, filed 10 Aug 2021.